The U.S. Food and Drug Administration has extended its review for the expanded use of Travere Therapeutics’ drug to treat a ...

Chronic kidney disease can quietly reshape a life long before the first lab test comes back abnormal. More than 700 million ...

In 2025, the FDA approved six drugs to treat various kidney diseases, including updates for Ozempic and the first approval of ...

One 26-year-old mother of six in Arkansas is reaching out for the public’s help as she battles stage 5 kidney failure and ...

Disagreement between creatinine and cystatin C kidney tests signals a much higher risk of serious disease and death, ...

Vertex on track for “five launches in five disease areas over a five-year period” through emerging pain and renal franchises.

A lot of the time, kidney problems start without any obvious signs, and the first signs are often very similar to dehydration ...

The incidence of kidney disease is substantially higher in patients with Down syndrome than in control individuals from the ...

Hypertension, diabetes, and cardiovascular disease are among the common causes of kidney failure. In the United States, approximately 35.5 million people have chronic kidney disease (CKD). 1 For some, ...

HPT, HP, and HK in the 7MM and a moderate sales growth forecast highlight market opportunities. Significant unmet needs and emerging pipeline products present avenues for market expansion and ...

The U.S. Food and Drug Administration has extended its review for the expanded use of Travere Therapeutics’ drug to treat a ...